Cafepharma Today

June 4 2025 - Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Massachusetts’ life sciences job growth flattens after 10+ years of increases
CDC official overseeing COVID-19 vaccine recommendations resigns
Lilly inks deal worth up to $870M to develop long-acting GLP-1 obesity drugs
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Generex sues TheStreet, Feuerstein for $250M
Fierce Biotech
Thursday, April 8, 2010 - 9:05am
tags:
Generex, lawsuits, journalists
Forest Labs Off 8% as FDA Torpedos Daxas
Barron's
Thursday, April 8, 2010 - 9:04am
tags:
Forest Labs, FDA, Daxas
Sanofi-Aventis to Pay as Much as $335 Million for CureDM Diabetes Drug
Bloomberg
Thursday, April 8, 2010 - 9:03am
tags:
Sanofi, diabetes, CureDM, liscensing
Teva Pharma receives FDA clearance for generic versions of Merck's Cozaar & Hyzaar drugs
Yahoo/AP
Thursday, April 8, 2010 - 9:02am
tags:
Merck, FDA, Teva Pharmaceuticals, generics, antihypertensives, Cozaar, Hyzaar
Drugmakers Spend Less On Vermont Doctors
Pharmalot
Wednesday, April 7, 2010 - 11:49am
tags:
Vermont, physicians, physican gifts, physicial payments
A blockbuster FDA deadline looms and Dendreon shares turn red-hot
Fierce Biotech
Wednesday, April 7, 2010 - 11:46am
tags:
Dendreon, Provenge, FDA, prostate cancer
Indian pharma decries patents granted Pfizer, Novartis
Fierce Pharma
Wednesday, April 7, 2010 - 11:45am
tags:
India, Pfizer, patents, Novartis, Eli Lilly
Pozen (POZN) Drug Treximet Forecasted To Sell Aggresively Due To Glaxo (GSK) Partnership
Yahoo/Wall Street Transcript
Wednesday, April 7, 2010 - 11:44am
tags:
GSK, Pozen, Treximet, partnerships
Britain Slashes Swine Flu Vaccine Order
Businessweek
Wednesday, April 7, 2010 - 11:41am
tags:
Great Britain, H1N1, vaccines, GSK
Allon, Genta programs win FDA fast-track status
Fierce Biotech
Wednesday, April 7, 2010 - 10:19am
tags:
FDA, Genta, Allon Therapeutics, fast track, Tesetaxel, davunetide
Johnson & Johnson's Dividend Hike Should Be Substantial
Seeking Alpha
Wednesday, April 7, 2010 - 10:18am
tags:
JNJ, Boston Scientific, dividends
As Novartis dips, bid for Alcon getting worse
Marketwatch
Wednesday, April 7, 2010 - 10:14am
tags:
Novartis, Alcon, M&A
AstraZeneca Seroquel Victory Upheld By Court
Pharmalot
Wednesday, April 7, 2010 - 10:12am
tags:
AstraZeneca, Seroquel
Pfizer Sees ‘Golden Age’ in Alzheimer’s, Cancer Drugs
Bloomberg
Wednesday, April 7, 2010 - 10:10am
tags:
Pfizer, cancer, Alzheimer's disease
China Drugmakers Rise to Highest in Month on Profit Prospects
Bloomberg
Wednesday, April 7, 2010 - 10:05am
tags:
China
14 Biotech Stocks Facing FDA Approval
TheStreet.com
Wednesday, April 7, 2010 - 10:01am
tags:
Cell Therapeutics, Pozen, AstraZeneca, Dendreon, InterMune, Questcor Pharmaceuticals, Novartis, Biogen Idec, Teva Pharmaceuticals, Merck Serono, Savient, Javelin, Alexza, Human Genome, Jazz Pharmaceuticals, Arena Pharmaceuticals, Vivus, Biodel
Drug Pipeline Pulse Check: Teva on a Tear
Seeking Alpha
Tuesday, April 6, 2010 - 3:53pm
tags:
Teva Pharmaceuticals, Abbott Laboratories, Amag Pharmaceuticals, AstraZeneca, Aeterna Zentaris, Cubist Pharmaceuticals, Keryx, KV Pharmaceutical, Eli Lilly, Novartis, Savient, Sanofi
Cephalon Acquires Ception
Yahoo/Zacks.com
Tuesday, April 6, 2010 - 3:26pm
tags:
Cephalon, Ception Therapeutics, M&A
Study: Sanofi's Multaq shouldn't be a first-line drug
Fierce Pharma
Tuesday, April 6, 2010 - 2:26pm
tags:
Sanofi, Multaq, atrial fibrillation
FDA Approves Reformulated OxyContin
WSJ Online
Tuesday, April 6, 2010 - 11:28am
tags:
FDA, oxycontin, Purdue

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.